TVGN
Tevogen Inc.
Company Overview
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
SectorHealthcare
IndustryBiotechnology
Market Cap$30.6M
Employees18
CEORyan H. Saadi
Websitehttps://tevogen.com
Valuation
Current Price$7.34
Fair Value?$000.00
Valuation?No valuation
Hist. PE ?N/Aⓘ
EPS (TTM) ?-5.64
Forward EPS Growth ?—
Historical Growth ?-81.01%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro
Price
EPS
Revenue
Equity
ProAvailable on the Pro plan
Free Cash Flow
ProAvailable on the Pro plan
Long Term Debt
ProAvailable on the Pro plan
Net Profit
ProAvailable on the Pro plan
Shares Outstanding
ProAvailable on the Pro plan
Last updated: 9/5/2026, 6:54:55 PM